%20CORP.%2C%20LTD./other/SHANGHAI_OBIO_TECHNOLOGY_GROUP_CORP.__QsWgeBs.png)
SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. — Investor Relations & Filings
SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the gene and cell therapy (GCT) sector. The company provides end-to-end solutions encompassing vector construction, process development, analytical method development, and large-scale GMP manufacturing. Its service portfolio includes the production of viral vectors such as adeno-associated virus (AAV), lentivirus, adenovirus, and oncolytic viruses, as well as plasmid DNA and cell therapy products. Obio Technology supports clients from early-stage research through clinical trials to commercialization. The company operates advanced facilities designed to meet international regulatory standards, facilitating the development of innovative genetic medicines and advanced therapies for global biopharmaceutical partners.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于投资设立海外全资子公司的进展公告 | 2023-02-03 | Chinese | |
| 关于拟购买资产的进展公告 | 2022-12-22 | Chinese | |
| 关于参与设立产业投资基金的公告 | 2022-12-07 | Chinese | |
| 关于子公司拟购买公租房的公告 | 2022-12-07 | Chinese | |
| 关于参与设立投资基金进展情况的公告 | 2022-11-29 | Chinese | |
| 关于召开2022年第三季度业绩说明会的公告 | 2022-11-22 | Chinese |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
1 filing
| |||||
| 40064948 | 关于投资设立海外全资子公司的进展公告 | 2023-02-03 | Chinese | ||
|
2022
14 filings
| |||||
| 40064939 | 关于拟购买资产的进展公告 | 2022-12-22 | Chinese | ||
| 40064930 | 关于参与设立产业投资基金的公告 | 2022-12-07 | Chinese | ||
| 40064920 | 关于子公司拟购买公租房的公告 | 2022-12-07 | Chinese | ||
| 40064907 | 关于参与设立投资基金进展情况的公告 | 2022-11-29 | Chinese | ||
| 40064900 | 关于召开2022年第三季度业绩说明会的公告 | 2022-11-22 | Chinese | ||
| 40064893 | 关于拟购买资产的公告 | 2022-11-18 | Chinese | ||
| 40064883 | 关于参与设立投资基金进展情况的公告 | 2022-11-14 | Chinese | ||
| 40064877 | 2022年第三季度报告 | 2022-10-26 | Chinese | ||
| 40064871 | 和元生物技术(上海)股份有限公司独立董事关于第三届董事会第一次会议相关事项的独立意见 | 2022-09-14 | Chinese | ||
| 40064864 | 海通证券股份有限公司关于和元生物技术(上海)股份有限公司首次公开发行网下配售限售股上市流通的核查意见 | 2022-09-14 | Chinese | ||
| 40064852 | 关于首次公开发行网下配售限售股上市流通公告 | 2022-09-14 | Chinese | ||
| 40064835 | 第三届监事会第一次会议决议公告 | 2022-09-14 | Chinese | ||
| 40064822 | 关于完成董事会、监事会换届选举及聘任高级管理人员的公告 | 2022-09-14 | Chinese | ||
| 40064807 | 关于选举公司第三届监事会职工代表监事的公告 | 2022-09-13 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58266/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58266 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58266 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58266 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58266}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. (id: 58266)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.